264 related articles for article (PubMed ID: 21851388)
1. Rivaroxaban for the prevention and treatment of venous thromboembolism.
Turpie AG
Fundam Clin Pharmacol; 2012 Feb; 26(1):33-8. PubMed ID: 21851388
[TBL] [Abstract][Full Text] [Related]
2. New anticoagulants for the prevention of thromboembolism.
Lepic K; Crowther M
Curr Pharm Des; 2010; 16(31):3472-4. PubMed ID: 20858184
[TBL] [Abstract][Full Text] [Related]
3. Practical management of new oral anticoagulants after total hip or total knee arthroplasty.
Klauser W; Dütsch M
Musculoskelet Surg; 2013 Dec; 97(3):189-97. PubMed ID: 24249360
[TBL] [Abstract][Full Text] [Related]
4. Novel oral anticoagulants for VTE prevention in orthopedic surgery: overview of phase 3 trials.
Friedman RJ
Orthopedics; 2011 Oct; 34(10):795-804. PubMed ID: 21956181
[TBL] [Abstract][Full Text] [Related]
5. [New oral anticoagulant drugs: dabigatran, rivaroxaban and apixaban. Present and future].
Dumont B; Faille D; Ajzenberg N
Med Sci (Paris); 2011 May; 27(5):493-500. PubMed ID: 21609670
[TBL] [Abstract][Full Text] [Related]
6. Dabigatran, rivaroxaban and apixaban versus enoxaparin for thomboprophylaxis after total knee or hip arthroplasty: pool-analysis of phase III randomized clinical trials.
Nieto JA; Espada NG; Merino RG; González TC
Thromb Res; 2012 Aug; 130(2):183-91. PubMed ID: 22425218
[TBL] [Abstract][Full Text] [Related]
7. Role of orally available antagonists of factor Xa in the treatment and prevention of thromboembolic disease: focus on rivaroxaban.
Morell J; Sullivan B; Khalabuda M; McBride BF
J Clin Pharmacol; 2010 Sep; 50(9):986-1000. PubMed ID: 20124518
[TBL] [Abstract][Full Text] [Related]
8. Indirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillation.
Lip GY; Larsen TB; Skjøth F; Rasmussen LH
J Am Coll Cardiol; 2012 Aug; 60(8):738-46. PubMed ID: 22575324
[TBL] [Abstract][Full Text] [Related]
9. Long-term benefits of preventing venous thromboembolic events.
Cohen AT
Curr Med Res Opin; 2012 Jun; 28(6):877-89. PubMed ID: 22533680
[TBL] [Abstract][Full Text] [Related]
10. Novel oral anticoagulants for thromboprophylaxis after orthopaedic surgery.
Quinlan DJ; Eriksson BI
Best Pract Res Clin Haematol; 2013 Jun; 26(2):171-82. PubMed ID: 23953905
[TBL] [Abstract][Full Text] [Related]
11. Rivaroxaban for the prevention of venous thromboembolism following major orthopedic surgery: the RECORD trials.
Ageno W
Expert Rev Cardiovasc Ther; 2009 Jun; 7(6):569-76. PubMed ID: 19505271
[TBL] [Abstract][Full Text] [Related]
12. Performance of new anticoagulants for thromboprophylaxis in patients undergoing hip and knee replacement surgery.
Mahan CE; Kaatz S
Pharmacotherapy; 2012 Nov; 32(11):1036-48. PubMed ID: 23124723
[TBL] [Abstract][Full Text] [Related]
13. Rivaroxaban for the prevention of venous thromboembolism: a single technology appraisal.
Stevenson M; Scope A; Holmes M; Rees A; Kaltenthaler E
Health Technol Assess; 2009 Oct; 13 Suppl 3():43-8. PubMed ID: 19846028
[TBL] [Abstract][Full Text] [Related]
14. Comparative efficacy and safety of the novel oral anticoagulants dabigatran, rivaroxaban and apixaban in preclinical and clinical development.
Ufer M
Thromb Haemost; 2010 Mar; 103(3):572-85. PubMed ID: 20135071
[TBL] [Abstract][Full Text] [Related]
15. [Budgetary impact for the National Health System of apixaban prophylaxis of venous thromboembolism in patients undergoing total knee or hip replacement].
Gómez Arrayas I; Suárez Fernández C; Gómez Cerezo JF; Betegón Nicolás L; de Salas-Cansado M; Rubio-Terrés C
Rev Esp Salud Publica; 2012 Dec; 86(6):601-12. PubMed ID: 23325135
[TBL] [Abstract][Full Text] [Related]
16. New oral anticoagulants--a review.
Ghanima W; Atar D; Sandset PM
Tidsskr Nor Laegeforen; 2013 Oct; 133(18):1940-5. PubMed ID: 24084970
[TBL] [Abstract][Full Text] [Related]
17. The promise of novel direct oral anticoagulants.
Hoffman R; Brenner B
Best Pract Res Clin Haematol; 2012 Sep; 25(3):351-60. PubMed ID: 22959551
[TBL] [Abstract][Full Text] [Related]
18. Anticoagulation: a GP primer on the new oral anticoagulants.
Brieger D
Aust Fam Physician; 2014 May; 43(5):254-9. PubMed ID: 24791763
[TBL] [Abstract][Full Text] [Related]
19. [Prophylaxis of venous thromboembolism in orthopedic surgery. Role of the new anticoagulants].
Guijarro Merino R; Villalobos Sánchez A
Med Clin (Barc); 2012 Oct; 139 Suppl 2():13-8. PubMed ID: 23498067
[TBL] [Abstract][Full Text] [Related]
20. Implications of new anticoagulants in primary practice.
Perez A; Eraso LH; Merli GJ
Int J Clin Pract; 2013 Feb; 67(2):139-56. PubMed ID: 23305476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
